US Patent Issued to Genentech on Aug. 12 for "Treatment of cancer using combination therapies comprising GDC-6036 and GDC-0077" (California Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,557, issued on Aug. 12, was assigned to Genentech Inc. (South San Francisco, Calif.).

"Treatment of cancer using combination therapies comprising GDC-6036 and GDC-0077" was invented by Mark Andrew Merchant (Redwood City, Calif.), Jennifer Lee Schutzman (Belmont, Calif.), Zhen Shi (Belmont, Calif.), Chunyan Song (Redwood City, Calif.), Neekesh Vijay Dharia (Burlingame, Calif.) and Stephanie Royer Joo (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are combination therapies comprising GDC-6036 and inavolisib and methods of using the same to treat cancer."

The patent was filed on April 4, 2023, under Application No. 18/295,55...